Millendo Therapeutics is a fertility company, engaged in developing proprietary treatments for female infertility based on scientific discoveries about the existence of egg precursor, or EggPCsm, cells. EggPC cells are undifferentiated germ cells from fetal development that may have the capacity to mature into eggs. Co.'s portfolio of treatment options uses its patented technology, including proprietary methods to isolate EggPC cells from a woman's own ovarian tissue. Co.'s other treatment include: OvaPrime, which is a fertility treatment that could help restore a woman's egg production; and OvaTuresm, which is a potential fertility treatment that eliminates the need for hormone stimulation. We show 25 historical shares outstanding datapoints in our OVAS shares outstanding history coverage, used to compute OVAS market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing OVAS market cap history over the course of time is important for investors
interested in comparing OVAS's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of OVAS versus a peer is one thing; comparing
OVAS market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like OVAS can fluctuate over the course of history.
With this page we aim to empower investors researching OVAS by allowing them to research the OVAS market cap history. |
Free OVAS Email Alerts:
Video: The Importance of Market Cap
